arrow
L

Lilin Lai

Center for Childhood Infections and Vaccines
H指数:43
被引数:9,630

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories

15个实验室SARS-CoV-2抗原性的全球协作比较

2024-12-180
OAAI
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
2024-05-152
PRE
AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans

AS03佐剂增强人类记忆b细胞对基于植物的新型冠状病毒肺炎疫苗反应的幅度,持久性和克隆广度

2024-04-055
OA
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults

一项2期临床试验,用于评估在健康美国成年人中使用和不使用AS03佐剂的2013年和2017 A(H7N9) 灭活流感病毒疫苗的安全性,反应原性和免疫原性

2024-03-274
PRE
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo
2023-11-292
PRE
BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer
2023-11-211
OAAI
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates
2023-10-2713
OAAI
Durability of immune responses to mRNA booster vaccination against COVID-19

针对新型冠状病毒肺炎的mRNA加强疫苗接种的免疫应答的持久性

2023-05-1530
OAAI
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster

mRNA二价增强剂对BA.2.75.2,BQ.1.1和XBB的中和作用

2023-01-12154
OAAI
Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
2022-10-0722
OAAI
A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection
2022-06-2429
OA
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses
2022-06-1413
OAAI
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

用临床相关佐剂辅助a亚单位SARS-CoV-2疫苗在小鼠中诱导持久保护

2022-05-2332
OAAI
Influenza virus-like particle-based hybrid vaccine containing RBD induces immunity against influenza and SARS-CoV-2 viruses
2022-05-010
OA
Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum
2022-02-086
OA
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
2022-02-01113
OAAI
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
2021-08-2041
OAAI